Skip to end of metadata
Go to start of metadata

Publication Request

Publication Request

1. Published Name of the Standard for which request is being made

DaVinci Payer Data Exchange US Drug Formulary

2. Standards Material/Document

Errata STU

3. Date of Request

Oct 26, 2020

4. Use Period

Two years

5. Reason for extension, timeline, and actions

6. Original Publication Date

7. End date of the current STU period

Jan 21, 2022

8. Length of the requested extension

9. Review Process

10. HL7 Work Group making this request and date

Pharmacy

10a. Requesting WG Date

Nov 02, 2020

11. URL of approval minutes

https://confluence.hl7.org/pages/viewpage.action?pageId=97453854

12. HL7 Product Management Group

FHIR Management

12a. Management Group Date of Approval

Nov 18, 2020

13. URL of approval minutes

https://confluence.hl7.org/pages/viewpage.action?pageId=97459634

14. Is the artifact ready for final publication?

Yes

15. If not ready, please describe remaining steps.

16. Tool name used to produce the machine processable artifacts in the IG

FHIR Shorthand

17. The name of the “IG artifact” within the context of the above mentioned tool.

18. Balloted Name of the standard for which request is being made

19. Requested name for published standard

20. If CMET, list IDs balloted

21. Project Insight Number

1489

22. Document Realm

US Realm

23. Ballot cycle in which the document was successfully balloted

24. Results of that ballot (following reconciliation activities):

24. Results of that ballot (following reconciliation activities):

(not needed for errata, STU extension, or unballoted STU update)

25. Affirmative

26. Negative

27. Abstentions

28. Not Returned

29. Total in ballot pool

30. Date on which final document/standards material was supplied to HQ

31. URL of publication material/ SVN repository

32. Publishing Facilitator

33. Special Publication Instructions

34. URL of ballot reconciliation document

35. Has the Work Group posted its consideration of all comments received in its reconciliation document on the ballot desktop?

36. Substantive Changes Since Last Ballot?

37. Product Brief Reviewed By

38. Date Product Brief Reviewed

39. Has the Product Brief changed?

No

Product Brief

Product Brief

40. Family

FHIR

41. Section

Implementation Guides

42. Topic

Pharmacy

43. Please Describe the Topic

44. Product Type

Implementation Guide

45. Parent standard

DaVinci Payer Data Exchange US Drug Formulary

46. Parent Standard Status

Active

47. Update/replace standard

Replaces published STU1 v1.0.0

48. Common name/search keyword

Formulary

49. Description

This implementation guide defines a FHIR interface to a health insurer's drug formulary information for patients/consumers. A drug formulary is a list of brand-name and generic prescription drugs a health insurer agrees to pay for, at least partially, as part of health insurance coverage. Drug formularies are developed based on the efficacy, safety and cost of drugs. The primary use cases for this FHIR interface enable consumers/members/patients to understand the costs and alternatives for drugs that have been prescribed, and to compare their drug costs across different insurance plans.

Targets

Targets

These are categories of potential users, implementers, or other interested parties such as those that are indicated on the Project Scope Statement under “Stakeholders/Vendors/Providers”. Select those that are applicable, or suggest others:

50. Stakeholders

Regulatory Agency, Standards Development Organizations (SDOs), Payors

51. Vendors

Pharmaceutical, EHR, PHR, Health Care IT

52. Providers

Emergency Services Healthcare Institutions (hospitals, long term care, home care, mental health)

53. Benefits

Same as v1.0.0 publication.

54. Implementations/Case Studies

Same as v1.0.0 publication.

55. Development Background